MAPS has begun its clinical trial of MDMA for people with autism.   After previous positive results applying the drug to patients with PTSD,  MAPS is now turning to people on the Autism Spectrum.     Potentially very exciting work.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s